How CMS plans to retool payments for antibiotics

CMS updated its payment system last week to make it easier for antibiotic companies to turn a profit, but the changes improve an already-established pathway rather than implementing an innovative subscription-based model as called for by former FDA Commissioner Scott Gottlieb and being evaluated by

Read the full 454 word article

User Sign In